Sign up to save your podcasts
Or
Share The Beacon
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Beacon
The Beacon episodes
- Dr. Charu Aggarwal (Part 1): Growing Momentum for Plasma-Based NGS Testing in Advanced NSCLC
Dr. West & Charu Aggarwal from University of Pennsylvania reviews data from her own group & other centers, demonstrating increasing practical utility & remaining limitations of liquid biopsy testing for molecular markers in advanced NSCLC.
27 min - Dr. Jack West: Why the Broader FDA Approval of First Pembrolizumab Monotherapy based on KEYNOTE-042 is an Invitation to Inferior Care in Advanced NSCLC
Dr. Jack West reviews why the new FDA approval of first line pembrolizumab monotherapy for the 1-49% PD-L1 subgroup won on a technicality and now offers a clearly inferior choice compared to far better existing standards for patients with low tumor PD-L1.
21 min - Dr. Jed Gorden (Part 2): Defining the Role of Interventional Pulmonology in a New Era of Lung Cancer Management
Drs. Jed Gorden and Jack West reflect on the evolving field of interventional pulmonology and their role not only in performing biopsies but also in longitudinally managing pleural effusions and pulmonary complications in patients with lung cancer.
21 min - Dr. Jed Gorden (Part 1): Rolling Out Chest CT Screening and Pulmonary Workups into the Real World Beyond Tertiary Care Centers
Dr. Jed Gorden speaks with Dr. Jack West, reviewing the obstacles limiting broader adoption of lung cancer screening in practice and how novel approaches are needed to reach areas outside of tertiary care hospitals.
26 min - Weighing the clinical significance of new clinical trial results with immunotherapy in stage III and IV NSCLC
Drs. Jack West & Corey Langer debate the criteria for adopting early clinical data as practice-changing as immunotherapy trials in locally advanced & metastatic NSCLC are reported.
20 min - Dr. Gil Morgan (Part 2): Overcoming Barriers in Cancer Care Delivery, Smoking Cessation, & Lung Cancer Screening Globally
Dr. Jack West & Sweden-based Dr. Gil Morgan discuss disparities in access & overall quality of cancer care, challenges in smoking cessation efforts, & the limited impact of lung cancer screening internationally.
26 min - Dr. Gil Morgan (Part 1): Social Media & Digital Education Cultivating a Global Oncology Community
Dr. Jack West & Sweden-based Dr. Gil Morgan reflect on how social media are forging new conversations & educational opportunities for the global oncology community, as well as the marked differences in cancer care & medical practice in the US vs. Sweden.
23 min - Dr. Giorgio Scagliotti: Shaping the Transformation of Thoracic Oncology
Drs. Jack West & Giorgio Scagliotti discuss the rapid evolution of lung cancer management as well as the practical bottlenecks & challenges limiting the quality of lung cancer care globally.
18 min - Dr. Alex Drilon: Clinical Research and the Changing Practice of Managing Molecularly-Defined, Narrow Subgroups
Drs. Jack West & Alex Drilon, from Memorial Sloan-Kettering, discuss opportunities & challenges of studying narrow molecularly-defined patient subgroups, (MET, RET, TRK, & others), along with the increasingly active role of online patient groups.
13 min - Drs. Christine Hann & Stephen Liu: Moving the Needle in Small Cell Lung Cancer
Dr. Jack West & guests, Drs. Christine Hann from Johns Hopkins & Stephen Liu from Georgetown, review recent potentially practice-changing results in small cell lung cancer (SCLC) & consider the challenges & future prospects for the SCLC landscape.
24 min
About The Beacon
From the publisher's feed
Dr. Jack West reviews emerging new information and controversial topics in health care in general, cancer treatment in particular.